Risk Factors for Primary Bone Cancer After Childhood Cancer: A PanCare Childhood and Adolescent Cancer Survivor Care and Follow-Up Studies Nested Case-Control Study.
Raoul C ReulenDavid L WinterIbrahima DialloCristina VeresDamien LlanasRodrigue Setcheou AllodjiFrancesca BagnascoEdit BárdiElizabeth Arnoldina Maria FeijenDaniela AlessiMiranda M Fidler-BenaoudiaStine HøgsholtJop C TeepenHelena LingeNadia HaddyJulianne ByrneGhazi DebicheDesiree GrabowThorgerdur GudmundsdottirRomain FaucheryWael Salem ZrafiGisela MichelHilde ØfstaasPeter KaatschGiao Vu-BezinHelen JenkinsonMelanie KaiserRoderick SkinnerTrevor ColeNicolas WaespeGrit SommerSusanne NordenfeltMomcilo JankovicTuomas Lähteenmäki TaalasMilena Maria MauleHelena J H Van der PalCécile M RonckersFlora E van LeeuwenJudith L KokMonica TerenzianiMaria Winther GunnesThomas WiebeCarlotta SacerdoteZsuzsanna JakabRiccardo HauptPäivi Maria LähteenmäkiLorna Zadravec ZaletelClaudia Elisabeth KuehniJeanette Falck WintherLeontien C M KremerLars HjorthFlorent de VathaireMichael M HawkinsPublished in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
increase the risk 7- to 8-fold, particularly following procarbazine, ifosfamide, and cyclophosphamide. These substantially elevated risks should be used to develop/update clinical follow-up guidelines and survivorship care plans.
Keyphrases
- childhood cancer
- young adults
- healthcare
- palliative care
- papillary thyroid
- low dose
- quality improvement
- squamous cell carcinoma
- high dose
- pain management
- mental health
- chronic pain
- health insurance
- squamous cell
- case control
- affordable care act
- bone mineral density
- human health
- soft tissue
- bone regeneration
- postmenopausal women